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Abstract Acute and chronic alveolar or bronchial
inflammation is thought to be central to the pathogenesis of
many respiratory disorders. Cytokines and granulocyte
macrophage colony-stimulating factors (GM-CSF) play an
important role in chronic inflammation. Activator protein-1
(AP-1) the superfamily of transcription factors is involved
in proliferation, differentiation, apoptosis, and transfor-
mation including inflammation. Understanding the function
and regulation of proinflammatory factors involved in
inflammation may provide the novel therapeutic strategies
in the treatment of inflammatory diseases. Our aim of the
present study is to investigate the pro-inflammatory
cytokines and pattern of AP-1 factors expressed during
activation of lung adenocarcinoma A549 cells by Phorbol-
12-myristate-13-acetate (PMA) and to understand the anti-
inflammatory effect of apigenin. A549 cells were treated
with and without PMA or apigenin, and the cell viability
was assessed by MTT assay. Expressions of inflammatory
mediators and different AP-1 factors were analyzed by
semi-quantitative RT-PCR. IL-6 protein secreted was
analyzed by ELISA, and expressions of IL-1b, c-Jun, and
c-Fos proteins were analyzed by Western blotting. Acti-
vation of A549 cells by PMA, induced the expression of
pro-inflammatory cytokine (IL-1b, IL-2, IL-6, IL-8, and
TNF-a) mRNAs and secretion of IL-6 and the expression
of specific AP-1 factors (c-Jun, c-Fos, and Fra-1). Treat-
ment of cells with apigenin, significantly inhibited PMA-
stimulated mRNA expression of above pro-inflammatory
cytokines, AP-1 factors, cyclooxygenase-2, and secretion
of IL-6 protein. Results suggested that the AP-1 factors
may be involved in inflammation and apigenin has anti-
inflammatory effect, which may be useful for therapeutic
management of lung inflammatory diseases.
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Introduction
Inflammation is a protective physiological response of the
body to activate the immune system in response to a variety
of stimuli, the infections, and tissue injury. However,
chronic inflammatory response may induce various dis-
eases such as sepsis, rheumatoid arthritis, and cancer [1, 2].
In response to bacterial infection or stimuli the pulmonary
epithelial cells present at the mucosal surface are capable
of secreting chemoattractants and pro-inflammatory cy-
tokines, the important mediators in both lung defense and
inflammation. Thus, the response of epithelial cells to in-
flammation acts as an early warning system to other local
immune and inflammatory cells [3]. Cytokines (IL-6, TNF-
a, IL-8, and Granulocyte–macrophage colony-stimulating
factor) are released in a coordinated network and among
interleukins IL-6 acts as a pro-inflammatory cytokine and a
potent mediator of inflammatory process [4]. In human
respiratory disease, pulmonary epithelial cells are one of
the major sources of prostaglandin E2 (PGE2) [5]. PGE2
are produced from arachidonic acid by inducible cy-
clooxygenase-2 (COX-2) [6, 7]. Induced expression of
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COX-2 and increased production of PGE2 have been im-
plicated in many inflammatory diseases and pulmonary
disorders [8]. Nitric oxide (NO) a free radical mediates
many physiological processes [9], and its production is
controlled by inducible isoforms nitric oxide synthase
(iNOS). Increased synthesis of NO in macrophages and
lung cells also lead to many organ destruction and
inflammatory autoimmune diseases.
The most studied transcription factors and most of the
information exist during immune and inflammatory
responses are nuclear factor-kappa-B (NF- kB) and acti-
vator protein-1 (AP-1) [10]. It is a well-known fact that
NF-kB plays an important role in immune system [11] that
regulate the expression of nearly all inflammatory me-
diators involved in inflammation [12]. AP-1 are involved in
proliferation, differentiation, apoptosis, transformation,
carcinogenesis, tumorigenesis, inflammation, and defense
reactions [13]. AP-1 is a dimeric transcription factor
comprising of proteins derived from two super families the
Jun (c-Jun, JunB, and JunD) and the Fos (c-Fos, FosB, Fra-
1, and Fra-2) proteins. Different combinational AP-1
dimers integrate numerous signaling pathways stimulated
by great variety of extracellular cues and hence synthesis
turnover of subunits of AP-1 transcription factors regulate
many physiological or pathological status of an organism.
Literature on AP-1 is very large, and the regulation and
expression of different AP-1 subunits during differen-
tiation, cell cycle, other pathophysiological processes,
inflammation in macrophages and lungs are well defined
[13, 14]. However, the expression pattern of different AP-1
factors in PMA-induced inflammation is less understood in
lungs.
Long-term administration of non-steroidal anti-inflam-
matory drugs (NSAIDs) in the treatment of inflammatory
diseases may result in severe adverse effects [15]. Hence,
many natural products particularly flavonoids with an al-
leged anti-inflammatory activity have been used in the
traditional medicine for treatment. Apigenin (40,5,7- tri-
hydroxyflavone), is a flavone that is the aglycone found
mainly in fruit, vegetables, nuts, and plant-derived bever-
ages, shown to have non-toxic, non-mutagenic [16], blocks
the development of mouse skin tumors [17], inhibits the
proliferation of human breast-cancer cells [18] and is a
potent antioxidant [19], apigenin is known to inhibit high
glucose levels and tumor necrosis factor-a (TNF-a)-in-
duced adhesion molecule levels in human endothelial cells.
Although large bodies of evidence exist in the use of api-
genin in the treatment of inflammation, not much is known
about its mechanism of anti-inflammatory action on AP-1
factors and pro-inflammatory cytokines in lungs. Hence in
the present study, we aimed to demonstrate the expression
pattern of different AP-1 factors on PMA-induced inflam-
mation and the effect of apigenin on PMA-induced pro-
inflammatory cytokines and AP-1 factors in human lung
adenocarcinoma A549 cells.
Materials and methods
Materials
Lung adenocarcinoma alveolar type II A549 cells were
purchased from NCCS (Pune, India), Phorbol 12-myristate
13-acetate (PMA), Apigenin, Griess reagent, oligos for-
ward and reverse primers for different cytokines and AP-1
factors, cell cycle regulators, and apoptosis gene sequences
were designed (Table 1) [20] and were purchased from
Sigma-Aldrich (St Louis, USA). Fetal bovine serum (FBS),
penicillin, streptomycin, glutamine, RPMI 1640 media,
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bro-
mide (MTT), dimethyl sulfoxide (DMSO), phenyl-
methanesulfonyl fluoride (PMSF), and trypan blue were
purchased from Himedia (Mumbai, India). Superscript re-
verse transcriptases for qRT-PCR and IL-6 ELISA Kit
were purchased from Invitrogen (CA, USA). Antibodies to
c-Jun, c-Fos, and IL-1b were purchased from Neo-Biolab
(MA, USA), and antirabbit antibody HRP conjugate was
purchased from Imgenex India Pvt. Ltd. (Bhubaneswar,
India). Taq DNA polymerase (1 U/ll) and Luminata Forte
Western HRP substrate was procured from Merck-Milli-
pore (Mumbai, India). Griess reagent was prepared in
distilled water containing 1 % sulfanilamide in 5 % phos-
phoric acid and 0.1 % N-l-naphthylethylenediamine dihy-
drochloride. The cell lysis buffer was prepared in distilled
water containing 50 mM Tris–HCl pH 8.0, 150 mM NaCl,
1.0 % NP-40, and 100 lM PMSF.
Culturing of A549 cells
A549 cells were grown in 75 cm2 culture flask in RPMI
1640 media with 10 % FBS, 100 U/ml penicillin and
100 lg/ml streptomycin and 2 mM L-glutamine. Cells
were cultured in a humidified atmosphere at 37 C by
passing 5 % CO2 in an incubator [21]. Flask containing
90–100 % confluent cells were sub-cultured in 96-well
plate (3 9 103 cells/well) or in 6-well plate (5 9 105cells/
well) for the treatment. (Whereever apigenin was used, the
cells were preincubated 1 h either with two different con-
centrations of apigenin (20 or 40 lM), and then stimulated
with PMA (10nM) for 2 and 24 h).
MTT assay for cell viability
MTT assay for cell viability was carried out as per the
protocol described earlier [22]. MTT is a pale yellow
substrate taken up and reduced by active live cell
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Table 1 Sequence of primers (F: forward and R: reverse) used for the amplification of different cytokines, inflammatory enzymes, AP-1 factors,
cell cycle regulators, and b-actin
Gene Primer sequence Annealing temp. (C) Product size (bp)
Cytokines and inflammatory enzymes
IL-1b F: AAACAGATGAAGTGCTCCTTCCAGG
R: TGGAGAACACCACTTGTTGCTCCA
62 388
IL-2 F: CCAAAGAGTCATCAGAAGAGG
R: GCACTTCCTCCAGAGGTTTGAG
64 470
IL-6 F: CCACTCACCTCTTCAGAACG
R: GACAGGTTTCTGACCAGAAG
58 564
IL-8 F: AGATATTGCACGGGAGAA
R: AACTAGGATTGTTAGTTC
55 671
IL-10 F: CCA AGA CCC AGA CAT CAA GGC
R: GAG CCC CAG ATC CGA TTT TGG
64 309
TNF-a F: CAAGCCTGTAGCCCATGTTGTAGC
R: ATCCCAAAGTAGACCTGCCCAGAC
58 430
iNOS F: TCACCTACCACACCCGAGAT
R: CATAGACCTTGGGCTTGCCA
57 384
COX-2 F: AGTCCCTGAGCATCTACGGT
R: AAAGGTGTCAGGCAGAAGGG
58 352
AP-1 factors
c-Jun F: GCCTACAGATGAACTCTTTCTGGC
R: CCTGAAACATCGCACTATCCTTTG
64 525
Jun-D F: CGCAGCCTCA AACCCTGCCT TTCC
R: AAACAGGAATGTGGACTCGTAG
64 500
Jun-B F: CCAGTCCTTCCACCTCGACGTTTACAAG
R: GACTAAGTGCGTGTTTCTTTTCCACAGTAC
58 257
c-Fos F: TCTTCCTTCGTCTTCACC
R: AATCAGAACACACTATTGCC
58 577
Fra-1 F: AGGAAGGAACTGACCGAC
R: GAAGGGGAGGAGACATTG
60 497
Fra-2 F: AGGAGGAGAGATGAGCAG
R: GGATAGGTGAAGACGAGG
60 518
Cell cycle regulators
Cyclin D1 F: AGACCTGCGCGCCCTCGGTG
R: GTAGTAGGACAGGAAGTTGTTG
58 574
Cyclin E1 F: GTCCTGGCTGAATGTATACATGC
R: CCCTATTTTGTTCAGACAACAT
60 415
CDK 4 F: AGTGGCGGATCCATGGCTACCTCTCGATAT
R: TCTCGGAAGCTTTCACTCCGGATTACCTTCA
60 912
P53 F: GAGCCCCCTCTGAGTCAG
R: GCAAAAACATCTTGTTGAG
56 375
Bcl-2 F: AGATGTCCAGCCAGCTGCACCTGAC
R: AGATAGGCACCCAGGGTGATGCAAGCT
62 365
Bax F: AAGCTGAGCGAGTGTCTCAAGCGC
R: TCCCGCCACAAAGATGGTCACG
61 366
b-actin F: TACCACTGGCATCGTGATGGACT
R: TCCTTCTGCATCCTGTCGGCAAT
62 516
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mitochondria to yield a dark blue formazan product. A549
cells (3x103cells/well) in 200 ll of RPMI-1640 medium
were seeded into 96-well culture plate and incubated
overnight at 37 C with the supply of 5 % CO2. Cells were
treated with or without various concentrations of PMA or
apigenin, incubated for 24 h, washed with PBS, treated
with 20 ll of MTT (5 mg/ml), and incubated further for
4 h at 37 C in a CO2 incubator. Blue formazan products
formed inside the cells were dissolved in DMSO (100 ll),
and absorbance was measured at 540 nm using spec-
trophotometer. The effect of PMA and apigenin on cell
viability was calculated and represented graphically as %
of viable cells compared to control.
Nitric oxide measurement
NO produced by A549 cells was assayed by the measure-
ment of nitrite, a stable NO oxidation product as described
earlier [23]. Cells (5 9 105cells/well) were plated in 6-well
culture plate and incubated at 37 C for 24 h in a hu-
midified 5 % CO2 incubator. Later, the cells were treated
with PMA (10nM) or apigenin (40 lM) alone or PMA with
apigenin (20 or 40 lM) for 24 h. Spent culture medium
aspirated from wells of culture plate (100 ll) was mixed
with 100 ll of Griess reagent, and the absorbance of the
mixture was measured in a microplate reader at 540 nm.
Concentration of nitrite in lM was calculated using stan-
dard curve developed with known concentration of sodium
nitrite.
RNA isolation and semi-quantitative RT-PCR analysis
A549 cells (5 9 105cells/well) were seeded into 6-well
plate and incubated with or without PMA (10nM) or PMA
and apigenin (20 lM or 40 lM) or apigenin alone (40 lM)
for 2 and 24 h. Total RNA was isolated from each of the
samples using ‘‘Trizol reagent’’ as per the instructions
provided by the manufacturer. Reverse transcription of
RNA and PCR analysis was carried out as per the protocol
described earlier [24]. In brief, total RNA (2 lg) was re-
verse transcribed using Oligo (dT) primers and superscript
reverse transcriptase. The cDNA was subjected to 30 cy-
cles of PCR using different forward and reverse primers of
inflammatory mediators or AP-1 factors or cell cycle
regulators or apoptosis genes using appropriate annealing
temperatures as indicated in Table 1 [20] in a gradient
Eppendorf thermocycler. Amplified PCR products were
analyzed on 1 % agarose gel using 1X TAE buffer. Rela-
tive mRNA levels were quantified using image analysis
software (ImageJ). The expression of b-actin mRNA was
used as a positive control and for normalization.
Enzyme-linked immunosorbent assay (ELISA)
A549 cells (5 9 105 cells/well) were seeded into six-well
plate and incubated with or without PMA (10nM) or PMA
and apigenin (20 lM or 40 lM) or apigenin alone (40 lM)
for 24 h. Cell-free culture supernatants (spent medium)
were collected and stored at -80 C until further used. The
amount of IL-6 protein present in spent medium was
measured using Invitrogen ELISA kit. Standard (100 ll) or
diluted control or treated samples (100 ll) were added into
wells of ELISA 96-well plate. The Biotin conjugate
(100 ll) was added, and incubated for 2 h at room tem-
perature. The wells were washed four times with wash
buffer, and 100 ll of Streptavidin–HRP solution was
added, incubated further for 30 min at room temperature.
The wells are washed thrice with wash buffer, 100 ll of
Chromogen was added, incubated for 20 min at room
temperature, and 100 ll of stop-solution was added to all
the wells. Absorbance was measured at 450 nm using the
PerkinElmer multimode plate reader (MA, USA). Con-
centrations of IL-6 in each samples were calculated using
standard curve drawn with known concentration of re-
combinant cytokines and represented graphically.
Western blotting of IL-1b, c-Jun, and c-Fos
The total cell protein extracts of A549 cells from control
and treated samples were prepared and analyzed by Wes-
tern blotting as per the protocol described earlier [24]. The
control and treated cells present in 6-well plate were
washed thrice with PBS, and 0.2 ml of cold cell lysis buffer
was added. Cells were scraped, and suspension was gently
transferred to a pre-cooled Eppendorf tube, mixed gently
by swirling on ice and centrifuged at 15,000 x g for 20 min
at 4 C. Supernatant was used to determine protein con-
centration by Bradford’s method [25]. The cell lysates
containing equal amount of protein (40 lg) of different
samples were separated on SDS–polyacrylamide gel elec-
trophoresis (SDS-PAGE) and electrophoretically trans-
ferred on to PVDF membrane. The membrane was blocked
with 5 % Carnation fat-free milk at room temperature for
1 h. Antibody (anti IL-1b or c-Jun or c-Fos) in blocking
solution (1:500) was added and incubated for 1 h, washed
and incubated with anti-rabbit antibody-HRP (1:500), and
further incubated for 1 h at room temperature. Im-
munoreactive proteins were visualized using Luminata
Forte Western HRP substrate and as per the specifications
provided by the supplier in a Syngene Gel Documentation
system (MD, USA). Immunoreactive bands were quantified
using image analysis software (ImageJ). GAPDH was used
as a positive control and for normalization.
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Statistical analysis
The MTT assay, nitric oxide production, the images of
semi-quantitative RT-PCR gels, ELISA, and Western
blotting data were analyzed by one-way ANOVA followed
by post-hoc tukey test. Values were considered statistically
significant if *P \ 0.05, **P \ 0.005 compared to control
and if #P \ 0.05 compared to PMA-treated sample.
Results
Effect of PMA and apigenin on A549 cells viability
The PMA used between 1-25nM concentration show no
effect on the cell viability, while at 50 nM PMA show
marginal decrease (5 %) in cell viability (Fig. 1a). Similar
results were also obtained by counting the number of viable
cells by trypan blue dye exclusion method using Neubauer
counting chamber (data not shown). To study the cytotoxic
effect of apigenin, A549 cells were treated with or without
different concentrations of apigenin (10-100 lM) for 24 h,
and the cell viability was determined by MTT assay. Re-
sults show that the apigenin up to 60 lM concentration
show no cytotoxic effect. However, compared to control a
marginal decrease in cell viability at 80 and 100 lM con-
centrations of apigenin was observed (Fig. 1b).
Effect of PMA and apigenin on Nitric Oxide production
in A549 cells
The A549 cells were treated with LPS or PMA (10nM) or
PMA and apigenin (20 or 40 lM) or apigenin (40 lM)
alone for 24 h, and the concentration of nitrite in spent
medium was determined using Griess reagent. The results
show that compared to control PMA alone has no effect on
nitric oxide production, while PMA with apigenin at 20 and
40 lM concentration show marginal decrease in nitric
oxide production. Apigenin alone also significantly inhib-
ited NO production (18 %) compared to control (Fig. 2).
The positive control LPS found to induce significantly the
nitric oxide production by more than 30 % compared to
control (Fig. 2).
Effect of PMA and apigenin on iNOS and COX-2
mRNA Expression
To assess the effect of PMA and apigenin on NO and PGE2
production in A549 cells, the mRNA levels of iNOS and
COX-2 were analyzed by semi quantitative RT-PCR. In
our study, PMA almost has no effect on iNOS expression,
but induced the COX-2 mRNA expression by more than
3.3-fold compared to control (Fig. 3a). The cells treated
with PMA with apigenin decreased the PMA-induced
mRNA levels of COX-2 in a dose-dependent manner. Cells
treated with apigenin (40 lM) alone also show more than
30 % decrease in the expression of iNOS and 69 % de-
crease in COX-2 mRNA levels compared to control
(Fig. 3a). However, the positive control LPS induced the
expression of iNOS by 34 % compared to control (Fig. 3b).
Apigenin inhibits the PMA-induced mRNA expression
of pro-inflammatory cytokines
Compared to control the treatment of A549 cells with PMA
both at 2 and 24 h significantly induced the expression of
all the pro-inflammatory cytokines (IL-1b, IL-6, IL-8, and
TNF-a). However, IL-2 was found to be induced only at
24 h but not at 2 h. Among the pro-inflammatory cytokines
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Fig. 1 Effect of different concentrations of (A) PMA and (B)
apigenin on the viability of A549 cells. Cells were treated with
or without different concentrations of PMA (1–50 nM) or
apigenin (10-100lM) in a 96-well plate for 24 h, and the cell
viability was measured by MTT assay. Results were expressed as %
viability of cells as compared to control (mean ± SD, n=8). Values
are significantly different from control if *P\0.05, **P\0.005
using one-way ANOVA followed by Post-hoc Tukey test. The
results are shown as a representative of three independent
experiments
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studied, at 24 h maximum induction of more than 5.8-fold
was observed for IL-6, 2.3-fold was observed for IL-2, and
twofold was observed for TNF-a mRNA levels. At 2 h
maximum induction of 2.7-fold was observed for IL-1b,
1.8-fold was observed for IL-8, and 1.7-fold was observed
for TNF-a mRNA levels compared to control. The cells
treated with apigenin (at 20 lM or 40 lM concentration)
for 24 h significantly inhibited the PMA-induced expres-
sion of mRNA levels of all the above pro-inflammatory
cytokines in a dose-dependent manner and almost reached
to control levels (Fig. 4b). At 2 h apigenin with 20 and
40 lM, significantly inhibited PMA induced the expression
of mRNA levels of IL-1b and TNF-a while marginal de-
crease was observed for IL-6. However, apigenin at both
the concentrations found to have no effect on IL-8 and IL-2
mRNA levels (Fig. 4a). The cells treated with apigenin
(40 lM) alone show no effect on IL-6, while significantly
decreased the expression of IL-1b, IL-2 IL-8, and TNF-a
mRNA levels compared to control (Fig. 4b). Further, PMA
and apigenin (20 and 40 lM) show no effect on anti-in-
flammatory IL-10 cytokine mRNA levels compared to
control.
Apigenin inhibits the PMA-Induced synthesis
and secretion of IL-6 cytokine
Treatment of A549 cells with PMA compared to control
show more than fivefold increase in the secretion of IL-6
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Fig. 2 Effect of PMA and apigenin on nitric oxide production. A549
cells were treated with LPS or PMA (10nM) or PMA with apigenin
(20 or 40lM) or apigenin (40lM) alone for 24 h, and the
concentration of nitrite in the spent medium was determined using
Griess reagent using sodium nitrite as standard. Data presented as
mean ± SD, n = 3. Values are significantly different from the control
if *P \ 0.05 using one-way ANOVA followed by Post-hoc Tukey
test. The results are shown as representative of three independent
experiments
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Fig. 3 Effect of (A) PMA or apigenin or PMA with apigenin (B) LPS
alone on the mRNAs of iNOS and COX-2 in A549 cells. A549 cells
(59105cells/well) were treated with or without PMA or PMA with
apigenin (20 or 40lL) or apigenin (40lL) alone or LPS alone for
24 h. The mRNA levels of amplified genes of qRT-PCR were
analyzed on 1 % agarose gel, and the band intensity of the
experimental samples was compared with the control and PMA
treatment alone. b-actin was used as a positive control and for
normalization. Data shown are means ± SD from 3 independent
experiments. Differences in inflammatory mediators mRNA levels are
statistically significant, if *P\0.05 compared with controls, #P\0.05
compared with PMA-stimulated values using one-way ANOVA
followed by Post-hoc Tukey test. The bar graphs present below the
respective figures are the densitometric analysis of mRNA levels
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protein into the medium. However, the cells treated with
PMA and apigenin significantly decreased the PMA-
induced IL-6 release in a dose-dependent manner. Cells
treated with apigenin (40 lM) alone show marginal
decrease in the secretion of IL-6 protein levels compared to
control (Fig. 5).
Apigenin inhibits the PMA-induced expression
of mRNAs of c-Jun and c-Fos AP-1 factors
A549 cells, except FosB, show the expression of mRNAs
of Jun (c-Jun, JunB, and JunD) and Fos (Fra-1, Fra-2, and
c-Fos) family members at different levels. Compared to
control the cells treated with PMA induced the expression
of c-Jun significantly by fourfold and fivefold, c-Fos by
2.6-fold and fourfold by 2 h and 24 h, respectively
(Fig. 6a, b). However, PMA marginally increased the
expression of Jun-D and Fra-1 mRNA transcripts by
0.2- and 0.6-fold, respectively, at 24 h (Fig. 6b). At 2 h
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Fig. 4 Effect of apigenin on PMA-induced mRNA expression of pro-
inflammatory cytokines (A) for 2 h and (B) for 24 h in A549 cells.
A549 cells (59105cells/well) were treated with or without PMA or
PMA with apigenin (20 or 40lL) or apigenin (40lL) alone for 2 and
24 h in 6-well plate. The mRNA levels of amplified genes of qRT-
PCR were analyzed on 1 % agarose gel and the band intensity of the
experimental samples was compared with the control and PMA
treatment alone. b-actin was used as a positive control and for
normalization. Data shown are means ± SD from 3 independent
experiments. Differences in proinflammatory cytokines mRNA levels
are statistically significant, if *P \ 0.05 compared with controls,
#P\0.05 compared with PMA-stimulated values using 1-way ANOVA
followed by Post-hoc Tukey test. The bar graphs present below the
respective figures are the densitometric analysis of mRNA levels
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Fig. 5 Effect of apigenin on PMA-induced synthesis and secretion of
IL-6 cytokine in to media from A549 cells. Cells (59105cells/well)
were treated with or without PMA or PMA with apigenin (20 or
40lL) or apigenin (40lL) alone for 24 h in a 6-well plate. The
amount of IL-6 released in the spent medium was determined by
ELISA. Each bar represents the mean ± SD, n=3, and significant at
the level of *P\ 0.05 compared to control, #P\ 0.05 compared to
PMA-stimulated values using one-way ANOVA followed by Post-
hoc Tukey test. The results are shown as a representative of three
independent experiments
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PMA significantly increased the expression of Jun-B by
1.7-fold and marginally increased the expression of Fra-1
by 0.2-fold and Fra-2 by 0.27-fold (Fig. 6a). The treatment
of cells with apigenin at 20 or 40 lM significantly
decreased the PMA-induced mRNA levels of c-Jun and
c-Fos in a dose-dependent manner. All most no inhibition
of PMA-induced Fra-1 mRNA levels at 20 and 40 lM
concentration of apigenin was observed. Cells treated with
apigenin (40 lM) alone showed marginal decrease in
mRNA level of Jun-B and significant increase in mRNA
transcripts of Fra-2 compared to control (Fig. 6b). The
results suggested that the c-Jun and c-Fos may be involved
in inflammatory reaction and apigenin show anti-inflam-
matory activity in lung cells.
Apigenin inhibits PMA-Induced expression of IL-1b,
c-Jun and c-Fos proteins in A549 cells
Our study also show that PMA induce significantly, the
IL-1b protein by twofold and c-Jun proteins by more than
2.9-fold while marginal of 0.57-fold increase was observed
for c-Fos. Apigenin at 20 lM and 40 lM concentrations
show significant decrease in PMA-induced IL-1b protein,
c-Jun, and c-Fos proteins in a dose-dependent manner (Fig. 7).
PMA induces the cell cycle regulators
Cells treated with PMA induced the expression of mRNA
levels of p53, CDK4, cyclin D1, and cyclin E1 transcripts at
different levels. Results show that the PMA induces p53
mRNA by 2 and CDK4 mRNA by more than twofolds and
marginal increase in 43 % of cyclin D1 mRNA levels (Fig. 8).
Apigenin treatment show the decreased PMA-induced ex-
pression of p53, cyclin D1 mRNA levels in a dose-dependent
manner. However, apigenin treatment, either with PMA or
alone show increased mRNA levels of CDK4 (Fig. 8), while
show decreased levels of cyclin E1 mRNAs suggested that the
apigenin has varied effect on cell cycle regulators.
Effect of PMA and apigenin on the expression
of apoptotic genes
A549 cells treated with PMA induced the expression of
mRNAs of Bcl-2 an anti-apoptotic gene, while decreased
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Fig. 6 Effect of apigenin on the PMA-induced expression of mRNAs
of AP-1 factors (A) for 2 h and (B) for 24 h in A549 cells. Cells were
treated with or without PMA or PMA with apigenin (20 or 40lL) or
apigenin (40lL) alone for 2 and 24 h in 6-well plate. The mRNA
levels of amplified genes of qRT-PCR were analyzed on 1 % agarose
gel, and the band intensity of the experimental samples was compared
with the control and PMA treatment alone. b-actin was used as a
positive control and for normalization. Data shown are means ± SD
from 3 independent experiments. Differences in AP-1 factors mRNA
levels are statistically significant: if *P \ 0.05 compared with
controls, #P\0.05 compared with PMA-stimulated values using one-
way ANOVA followed by Post-hoc Tukey test. The bar graphs
present below the respective figures are the densitometric analysis of
mRNA levels
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the pro-apoptotic Bax mRNA expression compared to
control (Fig. 9). However, treatment of cells with apigenin
(20 and 40 lM) decreased the PMA-induced Bcl-2 mRNA
expression and increased the Bax expression to control
mRNA levels. Apigenin alone found to have no effect on
Bcl-2 and Bax gene expressions.
Discussion
Phytochemicals are important and promising group of
compounds acts as a potential anti-inflammatory agents
because of their low toxicity and apparent benefit in the
treatment of acute and chronic diseases. Recently, the new
approaches on the use of herbal products for the treatment
of inflammatory diseases are being practiced in traditional
medicine but without understanding their associated com-
plications. Hence, our study focuses on the mechanism of
action of bioflavonoid the apigenin, which is extensively
used in alleviating the inflammatory diseases by inhibiting
cytokines and TNF-a [26]. Apigenin is an anti-inflamma-
tory molecule found in fruits and vegetables. Studies show
that the apigenin inhibits the production of cytokines [27]
and suppresses the LPS-induced NO production in mac-
rophages [28]. Apigenin also found to inhibit the LPS-
induced pro-inflammatory cytokine production in mono-
cytes, mouse macrophages [29] and blocks the collagenase
activity that is involved in rheumatoid arthritis. Apigenin
exhibit an anti-inflammatory activity in a mechanism in-
volving the action of heme oxygenese (HO-1) enzyme in
hPDL cells. [30]. In the present study, we demonstrate the
anti-inflammatory effect of apigenin on PMA-activated
human pulmonary epithelial cells. Apigenin up to 60 lM
concentration show no effect on the reduction in cell via-
bility as measured by MTT assay and suggested that the
flavonoid does not exhibit cytotoxic effect on lung cells.
The enzyme Nitric oxide synthase (NOS) is involved in
the synthesis of nitric oxide (NO). Although, NO plays a
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Fig. 7 Effect of apigenin on PMA-induced expression of IL-1b,
c-Jun, and c-Fos Protein levels in A549 cells. Cells were pretreated
with or without 40lM concentration of apigenin for 1 h and later
treated with or without PMA (10 nM) for 24 h. Cell lysates were
prepared with lysis buffer and equal amount of protein (40lg) of cell
lysates were analyzed on SDS PAGE, transferred on to PVDF
membrane. Expression levels of IL-1b, c-Jun, and c-Fos proteins in
PVDF membranes were analyzed using Western blotting technique,
and GAPDH was used as a positive control and for normalization.
Differences in protein levels are statistically significant: if *P\0.05
compared with controls, #P \ 0.05 compared with PMA treatment
using one-way ANOVA followed by Post-hoc Tukey test. The bar
graph present below the respective figures is the densitometric
analysis of protein levels
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Fig. 8 Effect of PMA on mRNA levels of cell cycle regulators. Cells
were treated with or without PMA (10 nM) or PMA with apigenin (20
or 40 lM) or apigenin (40lM) alone for 24 h in 6-well plate. The
mRNA levels of amplified genes of qRT-PCR were analyzed on 1 %
agarose gel, and the band intensity of the experimental samples was
compared with the control and PMA treatment alone. b-actin was
used as a positive control and for normalization. Differences in
cell cycle regulators mRNA levels are statistically significant: if
*P \ 0.05 compared with controls, #P \ 0.05 compared with PMA-
stimulated values using one-way ANOVA followed by Post-hoc
Tukey test. The results are shown as a representative of three
independent experiments. The bar graph present below the figure is
the densitometric analysis of mRNA levels
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beneficial role as anti-cancer and anti-viral molecule [31],
its extensive activation may lead to various inflammatory
diseases [32]. Hence, the decreased expression of inducible
nitric oxide synthase (iNOS) is regarded as a therapeutic
target for inflammation [33]. In our study A549 cells
treated with PMA has no effect on NO production. How-
ever, apigenin alone or PMA with apigenin marginally
inhibited NO production compared to control. The in-
hibitory activity of apigenin on NO production was also
reflected in the suppression of iNOS mRNA levels.
Another important major mediator of inflammation is
COX-2 enzyme, which catalyzes the biosynthesis of
prostaglandin-E2 from arachidonic acid [34]. In A549 cells,
COX-2 mRNA was expressed at low levels, but rapidly and
transiently induced by PMA. Apigenin significantly de-
creases the PMA-induced mRNA levels of COX-2 in a
dose-dependent manner which suggested the anti-inflam-
matory activity of flavonoid. Similarly in many tissues
COX-2 is undetectable, but was found to be transiently
induced by pro-inflammatory cytokines, growth factors,
oncogenes, and PMA [35].
In many tissues, the production of TNF-a and pro-in-
flammatory interleukins (IL-1b and IL-12) takes part in
immune response to many inflammatory stimuli and
overproduction of these mediators are detected in acute
septic hemorrhagic shock [36], and in chronic (rheumatoid
arthritis, atherosclerosis) inflammatory disorders [37, 38].
Our results show that within 2 h of treatment of lung cells
with PMA induced the expression of IL-1b, IL-6, IL-8, and
TNF-a, while at 24 h IL-2 the pro-inflammatory cytokine
was also induced. At 2 h of treatment of cells with apigenin
significantly inhibited the PMA induced expression of
mRNA levels of IL-1b and TNF-a while marginal decrease
was observed for IL-6. However, apigenin at 24 h sig-
nificantly decreased the expression of all the above pro-
inflammatory cytokines studied in a dose-dependent man-
ner. Treatment of A549 cells with PMA or PMA plus
apigenin show no effect on anti-inflammatory IL-10
mRNA levels, suggested the specificity of PMA as well as
apigenin action on pro-inflammatory cytokines. The
mRNA level of IL-6 present in the cell was also reflected in
the protein secretion. Treatment of cells with PMA shows
significant induction in the secretion of IL-6 protein into
the medium. However, the cells treated with PMA with
apigenin significantly decreased the PMA-induced IL-6
release in a dose-dependent manner. Cells treated with
apigenin (40 lM) alone show marginal decrease in the
secretion of IL-6 protein levels compared to control.
Western blotting result shows that treatment of cells with
PMA significantly induced expression of IL-1b. However,
PMA with apigenin significantly decreased the PMA-in-
duced IL-1b expression. Cells treated with apigenin
(40 lM) alone show decreased IL-1b protein expression
compared to control. IL-8, acts as an important mediator of
inflammation of CXC chemokine family recruits neu-
trophils into inflamed tissue [39]. Enhanced synthesis of
IL-8 has been shown in the intestinal mucosa of patients
suffering from inflammatory bowel disease (IBD) [37]. In
our study, apigenin also suppress the PMA-induced IL-8
mRNA expression levels suggesting the anti-inflammatory
effect of flavonoid in A549 cells.
In the present study, we also reported the expression
pattern of all the AP-1 factors (c-Jun, JunB, JunD and
c-Fos, Fra-1, and, Fra-2) except FosB in PMA-induced
inflammation and the effect of apigenin on the induced Jun/
Fos proteins. The cells treated with PMA induced the ex-
pression of c-Jun, JunB, Fra-1, Fra-2, and c-Fos by 2 h and
c-Jun and c-Fos by 24 h. However, PMA marginally in-
creased the expression of Jun-D and Fra-1 at 24 h, confirms
Jun and Fos family of AP-1 factors are early expressing
genes. The treatment of cells with apigenin significantly
decreased the PMA-induced mRNA levels of c-Jun and
c-Fos in a dose-dependent manner. All most no inhibition
of PMA-induced Fra-1 mRNA levels by apigenin was
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Fig. 9 Effect of PMA/apigenin on mRNA levels of Apoptotic genes.
Cells were treated with or without PMA (10 nm) or PMA with
apigenin (20 or 40 lM) or apigenin (40lM) alone for 24 h in 6-well
plate. The mRNA levels of amplified genes of qRT-PCR were
analyzed on 1 % agarose gel, and the band intensity of the
experimental samples was compared with the control and PMA
treatment alone. b-actin was used as a positive control and for
normalization. Differences in Apoptotic genes mRNA levels are
statistically significant: if *P \ 0.05 compared with controls,
#P \ 0.05 compared with PMA-stimulated values using one-way
ANOVA followed by Post-hoc Tukey test. The results are shown as
representative of three independent experiments. The bar graph
present below the figure is the densitometric analysis of mRNA levels
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observed. Cells treated with apigenin alone showed mar-
ginal decrease in Jun-B and significant increase in mRNA
transcripts of Fra-2 compared to control. The results sug-
gested that the c-Jun and c-Fos may be involved in in-
flammatory reaction and apigenin show anti-inflammatory
activity in lung cells and this needs further investigation.
Although all the Jun and Fos proteins are expressed in
A549 cells, only c-Jun, c-Fos, and Fra-1 were induced by
PMA. In normal lobular and ducts, the epithelial cells show
higher expression of FosB mRNA and protein, whereas in
majority of carcinomas and MCF-7 cells less of FosB
protein was expressed [40], and this is in agreement with
our study using A549 cells where little or no FosB mRNA
expression was observed.
Western blotting also confirms the induced expression
of c-Jun and c-Fos by PMA and apigenin decreased the
expression by 24 h. Further, our study also show that
PMA-induced p53 and cyclin D1 mRNA expression
modulated to control levels by certain extent by increased
concentration of apigenin. However, apigenin has
stimulatory effect on CDK4 expression that needs to be
investigated. Apigenin alone significantly decreased the
cyclin E1 mRNA levels suggested that the flavonoids may
have anti-proliferative and anti-cancerous effect on the
lung cells challenged with the phorbol esters. Apigenin also
show inhibitory effect on PMA-induced anti-apoptotic
Bcl2 gene, confirms the therapeutic property of flavonoid
[41] and probably has protective effect.
The anti-inflammatory effect of apigenin is probably
based on the modulation of pro-inflammatory gene expres-
sion of cyclo-oxygenase, lipoxygenase, nitric oxide syn-
thases, and several inflammatory cytokines and AP-1 factors
mainly acting through NF-jB and MAPK signaling [42].
Because of their essential role in intracellular signaling
network, MAPK pathways and the connected transcription
factors are appropriate targets for pharmacological treat-
ment of inflammatory disorders [43]. The flavonoids espe-
cially apigenin is required to be extensively investigated as
possible regulatory molecule(s) in inflammatory processes.
Conclusion
Our study demonstrate that the treatment of apigenin in-
hibits and modulate the PMA-induced mRNA expression
of cyclooxygenase-2 (COX-2) and pro-inflammatory cy-
tokines IL-1b, IL-2, IL-6, IL-8, and tumor necrosis factor-a
(TNF-a). Our study also confirms that apigenin decreased
the expression of IL-1b protein and synthesis and secretion
of IL-6. Apigenin also inhibited the PMA-induced ex-
pression of AP-1 factors (c-Jun and c-Fos) both at mRNA
and protein levels. Hence, apigenin is a valuable source of
new potential anti-inflammatory compound that may have
therapeutic potential for the modulation and regulation of
lung epithelial cell activation, and may provide safe and
effective treatment options for variety of lung inflamma-
tion-mediated diseases.
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